Literature DB >> 12757617

Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response.

Naoya Ukyo1, Toshiyuki Hori, Soshi Yanagita, Takayuki Ishikawa, Takashi Uchiyama.   

Abstract

The alloreactive immune response is a series of events initiated by the interaction of T cells with allogeneic dendritic cells (DCs), involving alloantigen recognition and costimulatory signals. In this study, we investigated the role of OX40 in alloreactivity in vitro. We first demonstrated that anti-OX40 ligand (anti-OX40L) monoclonal antibody (mAb) could markedly suppress the mixed leucocyte reaction (MLR) of peripheral blood mononuclear cells (PBMC). To further define the contribution of the OX40/OX40L system to the MLR, we set up a co-culture system of CD4+ T cells and allogeneic monocyte-derived dendritic cells (DCs). After 2 days, OX40 expression was induced on CD4+ T cells and this induction was strongly inhibited by the addition of cytotoxic T lymphocyte-associated antigen-4 (CTLA-4)-Fc fusion protein, suggesting that the expression of OX40 during alloreaction is dependent on CD28 signalling. Next we examined the effects of anti-OX40L mAb, CTLA-4-Fc fusion protein and anti-human leucocyte antigen (HLA)-DR mAb on the proliferative response of CD4+ T cells to allogeneic DCs. The proliferation of T cells was almost completely suppressed by anti-OX40L mAb, which was comparable with that of CTLA-4-Fc. Measurement of interleukin-2 (IL-2) production in the culture supernatants showed that suppression of a proliferative response was at least in part ascribed to reduced IL-2 production. Furthermore, purified OX40L- allogeneic DCs could induce considerable proliferation of CD4+ T cells, which was suppressed by anti-OX40L mAb. These results suggest that the OX40/OX40L system is crucial for induction of the allogeneic T-cell response and the OX40/OX40L system is subsequent to and dependent on CD28 signalling, but is crucial for the end outcome of the human alloreactive T-cell response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12757617      PMCID: PMC1782957          DOI: 10.1046/j.1365-2567.2003.01648.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  The effect of OX40/OX40L and CD27/CD70 pathways on allogeneic islet graft rejection.

Authors:  T Wu; B Hering; N Kirchof; D Sutherland; H Yagita; Z Guo
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

2.  Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion.

Authors:  J R Maxwell; A Weinberg; R A Prell; A T Vella
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

3.  Correlation of peripheral blood OX40+(CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation.

Authors:  A Kotani; T Ishikawa; Y Matsumura; T Ichinohe; H Ohno; T Hori; T Uchiyama
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

4.  Characterization of human inducible costimulator ligand expression and function.

Authors:  A Aicher; M Hayden-Ledbetter; W A Brady; A Pezzutto; G Richter; D Magaletti; S Buckwalter; J A Ledbetter; E A Clark
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

5.  Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation.

Authors:  N Tsukada; H Akiba; T Kobata; Y Aizawa; H Yagita; K Okumura
Journal:  Blood       Date:  2000-04-01       Impact factor: 22.113

6.  OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells.

Authors:  P R Rogers; J Song; I Gramaglia; N Killeen; M Croft
Journal:  Immunity       Date:  2001-09       Impact factor: 31.745

7.  Vascular endothelial cells provide T cells with costimulatory signals via the OX40/gp34 system.

Authors:  A Kunitomi; T Hori; A Imura; T Uchiyama
Journal:  J Leukoc Biol       Date:  2000-07       Impact factor: 4.962

8.  Compromised OX40 function in CD28-deficient mice is linked with failure to develop CXC chemokine receptor 5-positive CD4 cells and germinal centers.

Authors:  L S Walker; A Gulbranson-Judge; S Flynn; T Brocker; C Raykundalia; M Goodall; R Förster; M Lipp; P Lane
Journal:  J Exp Med       Date:  1999-10-18       Impact factor: 14.307

9.  Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors. Role of stimulator/responder ratio.

Authors:  H Tanaka; C E Demeure; M Rubio; G Delespesse; M Sarfati
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

10.  Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand.

Authors:  K Murata; N Ishii; H Takano; S Miura; L C Ndhlovu; M Nose; T Noda; K Sugamura
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

View more
  5 in total

Review 1.  Control of immunity by the TNFR-related molecule OX40 (CD134).

Authors:  Michael Croft
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

2.  Central Roles of OX40L-OX40 Interaction in the Induction and Progression of Human T Cell-Driven Acute Graft-versus-Host Disease.

Authors:  Trivendra Tripathi; Wenjie Yin; Yaming Xue; Sandra Zurawski; Haruyuki Fujita; Shino Hanabuchi; Yong-Jun Liu; SangKon Oh; HyeMee Joo
Journal:  Immunohorizons       Date:  2019-03

Review 3.  The significance of OX40 and OX40L to T-cell biology and immune disease.

Authors:  Michael Croft; Takanori So; Wei Duan; Pejman Soroosh
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

4.  Lentiviral gp34/OX40L gene transfer into dendritic cells facilitates alloreactive CD4+ T-cell response in vitro.

Authors:  Masayuki Kobayashi; Akifumi Takaori-Kondo; Keiko Fukunaga; Hiroyuki Miyoshi; Takashi Uchiyama
Journal:  Int J Hematol       Date:  2004-05       Impact factor: 2.490

5.  A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.

Authors:  Gillian Kinnear; Kathryn J Wood; Farnaz Fallah-Arani; Nick D Jones
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.